Biogen to Present at Bank of America Merrill Lynch Global Healthcare Conference London

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) announced today that it will present at Bank of America Merrill Lynch Global Healthcare Conference London. The webcast will be live on Friday, September 18, 2015 at 3:40p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit www.biogen.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150910006217/en/

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Source: Biogen Inc.

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
• Digitalist Group Plc’s Business Review, 1 January – 31 March 2024